Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Incorporated in 2012, Earum Pharmaceuticals Limited is engaged in the pharmaceutical business involving marketing, trading, and distribution of pharmaceutical formulation products.
Earum Pharmaceuticals' product range includes anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/antipyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections.
Currently, the company has its presence in Indian States such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan, Madhya Pradesh, Manipur, Assam, Meghalaya, Kerala, Telangana, etc., and intends to penetrate international markets as well.
| Issue Open | May 2, 2023 - May 31, 2023 |
| Security Name | Earum Pharmaceuticals Limited |
| Issue Size (Shares) | 246,716,400 |
| Issue Size (Amount) | ₹49.34 Crores |
| Issue Price | ₹2 per share |
| Face Value | ₹2 per share |
| Listing At | BSE |
| Terms of Payment | Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call. |
| Entitlement | 4 Equity Shares for every 1 Equity Shares held on the Record Date |
| Last Date to buy shares | April 6, 2023 |
| Record Date | April 10, 2023 |
| Credit of Rights Entitlements | April 26, 2023 |
| Bid/Offer Opens On | May 2, 2023 |
| Renunciation of Rights Entitlements | May 26, 2023 |
| Bid/Offer Closes On | May 31, 2023 |
| Deemed Date of Allotment | June 20, 2023 |
| Credit Date | June 21, 2023 |
| Listing Date | June 26, 2023 |
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
|---|---|---|---|---|
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
| Amount in ₹ Crore | ||||
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
16 3.9 Rating:  Vote Here ... |
Earum Pharmaceuticals Limited
A-1106, Empire Business Hub,
Near AUDA Water Tank, Science City Road,
Sola, Ahmedabad - 380060
Phone: (079)-48402525
Email: cs@earumpharma.com
Website: http://www.earumpharma.com
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
The Earum Pharmaceuticals Rights Issue 2023 opens on May 2, 2023, and closes on May 31, 2023.
Earum Pharmaceuticals Rights Issue 2023 Schedule
| Last Date for credit of Rights Entitlements | April 26, 2023 |
| Last Date for renunciation of Rights Entitlements | May 26, 2023 |
| Issue Opening Date | May 2, 2023 |
| Issue Closing Date | May 31, 2023 |
| Date of Allotment (on or about) | June 20, 2023 |
| Date of Credit (on or about) | June 21, 2023 |
| Date of Listing (on or about) | June 26, 2023 |
Earum Pharmaceuticals Rights Issue 2023 price is set at ₹2 per share per equity share.
The eligible shareholders are being offered 4 Equity Shares for every 1 Equity Shares held on the Record Date (April 10, 2023).
The record date for the Earum Pharmaceuticals Rights Issue 2023 is April 10, 2023.
The issue size of Earum Pharmaceuticals Rights Issue 2023 is of 246,716,400 equity shares at ₹2 per share aggregating upto ₹49.34 Crores.
The Letter of Offer for Earum Pharmaceuticals Rights Issue 2023 can be download here.
You can apply for Earum Pharmaceuticals Rights Issue 2023 in two ways:
Steps to apply for Earum Pharmaceuticals Rights Issue 2023 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Earum Pharmaceuticals Rights Issue 2023 using Registrar's website (R-WAP)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
